But as market forces shift and client expectations evolve, many forward-thinking firms are starting to break free from “the ...

LONDON, Feb 20 (Reuters) - Anglo American (AAL.L), opens new tab posted a $3.1 billion loss on Thursday after a writedown of its De Beers diamond business, as it presses on with shedding unwanted ...

LONDON (Reuters) -Anglo American posted a $3.1 billion loss on Thursday after a writedown of its De Beers diamond business, as it presses on with shedding unwanted assets. Anglo aims to focus on ...

SANTIAGO, Feb 20 (Reuters) - Chilean state-run copper giant Codelco (COBRE.UL) and London-listed miner Anglo American (AAL.L), opens new tab signed a memorandum of understanding to jointly operate ...

Olafur Eliasson, Patricia Piccinini, Nick Cave, Yayoi Kusama, Archie Moore’s Venice work – just some of the headlining ...

JPMorgan analyst Dominic O’Kane raised the firm’s price target on Anglo American (NGLOY) to 2,190 GBp from 2,160 GBp and keeps a Neutral rating on the shares. See what stocks are receiving ...

Berenberg Bank analyst Richard Hatch maintained a Sell rating on Anglo American (AAUKF – Research Report) yesterday and set a price target of p2,100.00. The company’s shares closed yesterday ...

Premium VOD revenues in Southeast Asia in 2024 surged by 14% to reach $1.8BN, with Max having an encouraging debut, according to the latest report by Media Partners Asia (MPA). Max’s launch in ...

Southeast Asia‘s premium video-on-demand market saw robust growth in 2024, with total industry revenues jumping 14% to $1.8 billion and viewership hitting 440 billion minutes, according to fresh ...

Meghan Markle is once again at the center of controversy after unveiling the new name and logo for her rebranded lifestyle venture, As Ever. On February 18, the Duchess of Sussex announced the ...

Gupta’s ascent to power hands control of the capital city to Prime Minister Modi’s party for the first time in 27 years. New Zealand storm to 60-run victory in Champions Trophy opener as hosts ...

(Reuters) -AstraZeneca will buy longtime partner FibroGen's China unit for about $160 million to gain rights to its anemia drug in the country, further boosting its presence in the world's second ...